BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19265861)

  • 1. The g.-762T>C polymorphism of the NPC1L1 gene is common in Chinese and contributes to a higher promoter activity and higher serum cholesterol levels.
    Chen CW; Hwang JJ; Tsai CT; Su YN; Hsueh CH; Shen MJ; Lai LP
    J Hum Genet; 2009 Apr; 54(4):242-7. PubMed ID: 19265861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Niemann-Pick C1-like 1 (NPC1L1) genetic polymorphisms and haplotypes in Chinese Han population.
    Lou XY; Qin CZ; Bao MH; Hu DL; Chen F; Sun H; Chen Y; Guo D; Zhang W; Cheng Y; Zhou HH
    Pharmazie; 2015 Sep; 70(9):581-5. PubMed ID: 26492642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
    Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
    Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.
    Kashiwabara Y; Kobayashi Y; Koba S; Kohyama N; Ohbayashi M; Murayama JI; Hirano T; Kobayashi Y; Yamamoto T
    J Clin Pharm Ther; 2014 Oct; 39(5):551-4. PubMed ID: 24861377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rs2072183 SNP and serum lipid levels in the Mulao and Han populations.
    Miao L; Yin RX; Hu XJ; Wu DF; Cao XL; Li Q; Yan TT; Aung LH; Wu JZ; Lin WX
    Lipids Health Dis; 2012 May; 11():61. PubMed ID: 22646906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SNP of NPC1L1 affects cholesterol absorption in Japanese.
    Maeda T; Honda A; Ishikawa T; Kinoshita M; Mashimo Y; Takeoka Y; Yasuda D; Kusano J; Tsukamoto K; Matsuzaki Y; Teramoto T
    J Atheroscler Thromb; 2010 Apr; 17(4):356-60. PubMed ID: 20379057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.
    Simon JS; Karnoub MC; Devlin DJ; Arreaza MG; Qiu P; Monks SA; Severino ME; Deutsch P; Palmisano J; Sachs AB; Bayne ML; Plump AS; Schadt EE
    Genomics; 2005 Dec; 86(6):648-56. PubMed ID: 16297596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.
    Zsíros N; Bodor M; Varga V; Berta E; Balogh I; Seres I; Paragh G; Harangi M
    Pharmazie; 2014 Jun; 69(6):424-9. PubMed ID: 24974575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NPC1L1 Polymorphism 1679C>G Is Associated with Gallstone Disease in Chinese Patients.
    Wu J; Cui W; Cai Q; Fei J; Zhang SD; Han TQ; Hu H; Jiang ZY
    PLoS One; 2016; 11(1):e0147562. PubMed ID: 26800364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
    Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
    Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An NPC1L1 gene promoter variant is associated with autosomal dominant hypercholesterolemia.
    Martín B; Solanas-Barca M; García-Otín AL; Pampín S; Cofán M; Ros E; Rodríguez-Rey JC; Pocoví M; Civeira F
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):236-42. PubMed ID: 19747803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human NPC1L1 expression is positively regulated by PPARα.
    Iwayanagi Y; Takada T; Tomura F; Yamanashi Y; Terada T; Inui K; Suzuki H
    Pharm Res; 2011 Feb; 28(2):405-12. PubMed ID: 20953676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe.
    Hegele RA; Guy J; Ban MR; Wang J
    Lipids Health Dis; 2005 Aug; 4():16. PubMed ID: 16098225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).
    Garcia-Calvo M; Lisnock J; Bull HG; Hawes BE; Burnett DA; Braun MP; Crona JH; Davis HR; Dean DC; Detmers PA; Graziano MP; Hughes M; Macintyre DE; Ogawa A; O'neill KA; Iyer SP; Shevell DE; Smith MM; Tang YS; Makarewicz AM; Ujjainwalla F; Altmann SW; Chapman KT; Thornberry NA
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8132-7. PubMed ID: 15928087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin.
    Kumar P; Malhotra P; Ma K; Singla A; Hedroug O; Saksena S; Dudeja PK; Gill RK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G148-55. PubMed ID: 21527728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.
    Temel RE; Tang W; Ma Y; Rudel LL; Willingham MC; Ioannou YA; Davies JP; Nilsson LM; Yu L
    J Clin Invest; 2007 Jul; 117(7):1968-78. PubMed ID: 17571164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common single nucleotide polymorphisms at the NPC1L1 gene locus significantly predict cardiovascular risk in coronary patients.
    Muendlein A; Leiherer A; Saely CH; Rein P; Zanolin D; Kinz E; Brandtner EM; Fraunberger P; Drexel H
    Atherosclerosis; 2015 Sep; 242(1):340-5. PubMed ID: 26253792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular loop C of NPC1L1 is important for binding to ezetimibe.
    Weinglass AB; Kohler M; Schulte U; Liu J; Nketiah EO; Thomas A; Schmalhofer W; Williams B; Bildl W; McMasters DR; Dai K; Beers L; McCann ME; Kaczorowski GJ; Garcia ML
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11140-5. PubMed ID: 18682566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.
    Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW
    Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia.
    De Castro-Orós I; Pérez-López J; Mateo-Gallego R; Rebollar S; Ledesma M; León M; Cofán M; Casasnovas JA; Ros E; Rodríguez-Rey JC; Civeira F; Pocoví M
    BMC Med Genomics; 2014 Apr; 7():17. PubMed ID: 24708769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.